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I. The agreement 
On  the  basis  of the  negotiating  directives  issued  by  the  Council,  the  European 
Commission has  negotiated  and  initialled  an  agreement  on  the  mutual  recognition  of 
good  laboratory practice  and  compliance  monitoring  programmes  (mutual  recognition 
agreement on GLP).  The text of the agreement initialled in January 1997 is  attached at 
annex. 
This Explanatory Memorandum provides an assessment of the agreement in the light of 
the negotiating directives issued by the Council, and recommends that the Council adopt 
a decision approving the agreement. 
1.1 Assessment of  the agreement 
The  Commission  considers  that  the  initialled  agreement  is  in  conformity  with  the 
Council's negotiating directives, takes account of the views expressed by the Article 113 
Committee's Technical Group on Mutual Recognition, which gave detailed advice to the 
Commission during the negotiations, and provides benefits to the European Community. 
The  Member  States  have  at  present  a  considerable  number  of GLP-recognised  test 
facilities.  The  list will be  sent to  Israel,  which  at  present has  only  two  test  facilities 
~pplying for GLP recognition  .. 
Both parties are sufficiently confident for work to continue. 
1.1.1 The content of  the agreement 
The agreement consists of a preamble and  16  articles, and two annexes.  Its content is 
examined below. 
The  preamble  sets  out  the  objectives  of the  mutual  recognition  agreement  on  good 
laboratory practice. 
Article l, Definitions, defines certain terms used. 
Article 2, Purpose, lays down the objective of  the agreement, i.e. the parties' commitment 
to ensure the quality, validity and reliability of the data on the evaluation of  the safety of 
chemicals  covered  by  the  agreement,  recognition  of GLP  compliance  monitoring 
programmes,  mutual  acceptance  of data  and  studies  generated  by  each  party's  test 
facilities and the use of these data and studies for the administrative procedures required 
to authorise the marketing of  the chemicals referred to in the annex. 
2 Article  3,  Legal  Basis,  lays  down  the  conditions  which  must  be  fulfilled  to  obtain 
recognition, i.e.  the principles of good laboratory practice and the provisions regarding 
test facility inspection must be in accordance with the OECD decisions. 
Article  4,  Field  of application, 'lays  down  that  the  agreement  applies  to  the  studies 
conducted on chemicals as listed in Annex 1. 
Article  5,  Monitoring  Authorities,  lays  down  that  Annex  2  will  contain  the  list  of 
authorities which monitor test facilities' conformity and that the joint committee set  up 
under the agreement will decide on changes to the list. 
Article 6, Information about GLP-recognised Test Facilities, provides for the exchange of 
information between the two sides on the test facilities recognised as conforming to good 
laboratory practice, the results of  the inspections, and laboratories which fail to conform. 
Article  7,  Additional  Actions,  lays  down  the  obligation  to  supply  in  response  to  a 
reasoned request any  necessary information on  inspections.  In  the  event of reasonable 
doubt,  one  party may ask  the  other to  conduct additional  inspections  or audits  on its 
territory.  In exceptional cases, a party may designate, with the other party's agreement, 
one or more experts to take part in the inspection or audit. 
Article  8,  Confidentiality, obliges the parties to  maintain confidentiality in the case of 
confidential information resulting from  GLP  complian~e monitoring.  It  lays down that 
the test facilities inspected will have access to the reports which concern them. 
Article 9, Participation as Observer, lays down that a party may, on request, participate as 
an observer in an  inspection of  a test facility.  In  particular it lays down that the Israeli 
authority may take part in the Community mutual joint visit programme. 
Article 10, Joint Committee, sets up a committee of  representatives of  the two sides to try 
and settle possible differences in views and practices, and to ensure the proper working of 
the agreement and strengthen cooperation. 
Transitional provisions 
Transitional provisions are described in Articles 11, 12 and 13. 
Article  11  lays  down  that these provisions apply during an  initial  period  (transitional 
arrangements) of a maximum of two years from  the entry into force of the agreement. 
This  period  should  make  it  possible  to  introduce  a  national  compliance  monitoring 
scheme in Israel. 
Under Article  12  the authorities empowered by the Community will monitor, over the 
transitional period, the conformity of  the test facilities in Israel with GLP. 
Article  13  lays  down  that,  during the transitional  period,  Israel  wiH  accept  data from 
GLP-recognised test facilities in the Community and that Member States will accept data 
from  the  Israeli  test  facilities  which  are  GLP-recognised  by  a  Member  State;s 
monitoring authority . 
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Final provisions 
The final provisions are laid down by Articles 14, 15 and 16. 
Article 14 lays down that the agreement may be terminated with six months' notice. 
Article  15  lays down that the agreement applies to the territories in which the. Treaty 
establishing the European Community applies and the territory of  Israel. 
Article 16 contains the standard institutional and legal provisions. It should be noted that 
the agreement is of  unlimited duration. 
1.1.2 Ann~xes 
Annex 1 
This Annex contains the list of  chemicals covered by the agreement, and the references to 
the legislation of  each of  the parties to the agreement. 
Annex2 
This Annex contains the list of  the monitoring authorities. 
1.1.3 Relations with EFTA countries and the EEA Member States 
In accordance with the  general information and consultation procedures set out in  the 
EEA Agreement and Protocol 12 of the EEA Agreement, the Commission has kept the 
EFT  A countries and the  EEA Member States  regularly  informed of the  progress and 
outcome of  the negotiations. 
1.1.4 Overall assessment 
The Commission considers that the agreement has benefits for the two sides. 
The  Community  studies  and  data  generated  }?y  non-clinical  experiments  with  the 
chemicals concerned will be recognised by  Israel  as soon as the agreement enters into 
force.  Community exporters may therefore use these data and studies from Community 
test facilities  in the procedures for  authorising marketing in  Israel,  and this  will  help 
Community exports. 
The  two-year  transitional  period  will  make  it  possible  to  set  up  Israel's  compliance 
monitoring system. The empowered authorities in the Community will have to assess the 
reliability of this system and will therefore have to decide when the transitional period 
can be ended. 
4 II. Propotal for a Cot~adl Deeisiefl 
A proposal for a Council Decision on the conclusion of the Agreement is attached. The 
Decision has two objectives: 
(a)  to approve the draft agreement on the basis of  Article. 113  and 221 of  the Treaty; 
and 
(b)  to  establish a  Community procedure to enable the  Commisaion,  aui.sted by the 
Article 113 Committee (Technical Group on Mutual Recognition), to represent the 
Community in the joint committee and to determine the Comm.unity position in that 
joint committee in case of  changes to the annexes or any other matter set out in the 
Decision, in accordance with Article 228(4) of  the Treaty, following consultation of 
the Article 113 Committee. 
On this  second  aspect,  it  is  noted  that  Article  10  of the  agreement  sets  up  a joint 
committee. It is responsible for the management of the agreement and has the delegated 
power to amend the two annexes.  Such right of amendment is  restricted to  procedural 
issues concerned with implementation, namely mainly amending the  references to  the 
chemicals  concerned  and  to  the  legislation  applicable,  and  amending  the  list  of 
compliance monitoring authorities. 
It is therefore proposed that: 
(a)  the  Commission,  assisted  by  the  Article 113  Committee  (Technical  Group  on 
Mutual Recognition), should represent the Community within the joint committee 
set up and determine in the committee the Community position on any change to 
the annexes or any other matter concerning the management of the agreement, in 
accordance  with  Article 228(4)  of the  Treaty,  following  consultation  of the 
Committee mentioned above. 
(b)  for all other matters, the Community position should be adopted by the Council, 
acting by a qualified majority on a proposal from the Commission. 
The Commission therefore proposes that the Council adopt the attached Decision, and 
indicate the person empowered to sign the agreement on behalf of  the Community. 
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Proposal for a 
COUNCIL DECISION 
on the conclusion of an agreement between the European Community and Israel 
on mutual recognition of OECD principles of good laboratory practice and 
compliance monitoring programmes 
THE COUNCIL OF THE EUROPEAN UNION, 
Having regard to  the  Treaty  establishing the  European  Community,  and  in  particular 
Article 113 thereof, read in conjunction with the first sentence of Article 228(2) and the 
first subparagraph of-Article 228(3) and Article 228(4), 
Having regard to the proposal from the Commission, 
Whereas the Agreement on mutual recognition of OECD principles of good laboratory 
practice  and  compliance  monitoring  programmes,  initialled  in  Brussels  on 
16 January 1997, was negotiated by the Commission in accordance with its negotiating 
guidelines and should be approved; 
Whereas certain aspects of implementation have been assigned to  the joint committee 
established by the Agreement, and in particular the power to amend certain parts of the 
two annexes; 
Whereas  it is  necessary  to  lay  down  the  internal  procedures  required  for  the  proper 
functioning of the Agreement; whereas the Commission should be empowered to make 
·certain technical changes to the Agreement and to take certain decisions concerning its 
implementation, 
HAS DECIDED AS FOLLOWS: 
Article 1 
The Agreement between the European Community and Israel on mutual recognition of 
OECD principles of good laboratory practice and compliance monitoring programmes is 
-hereby approved on behalf of  the European Community. 
The text of  the Agreement and the agreed minutes are attached to this Decision. 
Article 2 
The  President  of the  Council  shall,  on  behalf of the  Community,  transmit  the  note 
provided for in Article 16 of  the Agreement•. 
•  The  date  of entry  into  force  of the  Agreement  will  be  published  in  the  Official  Journal  of the 
European Communities. 
6 Article 3 
1.  The Commission, assisted by the special committee appointed by the Council, shall 
represent the Community in the joint committee provided for in Article  10 of the 
Agreement. After consulting the special committee, the Commission shall carry out 
the  notifications,  consultations  and  exchanges  of information,  shall  make  the 
requests for inspections and for participation in inspections, and, if need be, shall 
reply  to  requests,  in  accordance  with  Articles 3(2),  5(2),  6,  7,  9  and  I 2  of the 
Agreement  and  in  Annex  2  thereto,  and  adopt  the  Decision  provided  for  in 
Article 11(2) and (3) and the second sentence of  Article 12. 
2.  The  position  of the  Community  within  the  joint  committee,  with  regard  to 
amendments to Annex 1 decided upon in accordance with the second sentence of 
Article  4  of the  Agreement  and  to  amendments  to  Annex  2  decided  upon  in 
accordance  ,with  Article  5  of  the  Agreement,  shall  be  adopted  by  the 
Commission after it has consulted the special committee referred to in paragraph 1 
of  this Article. 
3.  All other decisions shall be taken by the Council, acting by a qualified majority on 
a proposal from the Commission. 
Done at Brussels, 
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For the Council 
The President 
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AGREED MINUTES 
Concerning 
AGREEMENT 
I 
on Mutual Recognition ofOECD principles 
of  Good Laboratory Practice (GLP) 
and Compliance Monitoring Programmes 
between the European Community and the State of  Israel 
8 I.  Preliminary AGREED MINUTES 
1 annex:  List  of  Israeli  test  facilities  candidates  to  be  GLP 
recognised. 
II.  AGREEMENT (DRAFT) containing: 
16 Articles 
2 Annexes: 
Annex 1: 
Annex2: 
List of Chemicals covered  by the Agreement on Mutual 
Recognition  of OECD  Principles  of Good  Laboratory 
Practice and Compliance Monitoring Programmes between 
the Emopean Community and the State of  Israel. 
List of  Monitoring Authorities. 
9 AGREED MINUTES 
CONCERNING 
AGREEMENT 
on Mutual Recognition of  OECD principles 
of  Good Laboratory Practice (GLP) 
and Compliance Monitoring Programmes 
between the European Community and the State of  Israel 
Having  regard to  the  Transitional  Provisions  of the  draft ·Agreement  enclosed  on 
Mutual Recognition of  OECD Principles of  Good Laboratory Practice (GLP) between the 
European  Community  (EC)  and  the  State  of Israel  the · Contracting  Parties  state 
as follows: 
TEST FACILITIES CONCERNED 
The list of  test facilities that Israel wants to be GLP recognised is annexed to the 
present minute. 
PRELIMINARY MISSION 
Before the signature of the Agreement, a preliminary mission of two experts of 
the EC will take place in order to: 
•  assess  the  state  of affairs  concerning  the  test  facilities  in  Annex  that 
eventually could be GLP recognised; 
•  give their advice for the setting up of  the national GLP Monitoring Authority. 
Both Parties agree to accept the findings of the report of the experts concerning 
the above mission as submitted. 
10 INITIAL PERIOD 
All  inspections  during  the  initial  period  will  be  performed  by  at  least 
two inspectors designated by the EC. 
The reports of these inspections will be sent by the inspectors to  the test facility 
concerned and, in addition, to the authorities of  the Contracting Parties!. 
Inspections will start as soon as possible after the signature of  the Agreement and 
upon  request  of the· Israeli  Authorities,- in  order  to  inspect  the  test  facilities 
interested to be GLP recognised. 
All the costs pertaining to the missions - both the preliminary mission and the 
inspections during the initial period- will be supported by the State of  Israel. 
For the Government of the State of  Israel 
European Commission: 
DGI/M/2 
Rue de Ia Loi, 200 
I  049 Brussels (Belgium). 
Israel Laboratory 
Accreditation Authority 
Habonim Street, 2 
Ramat Gan 52522 (Israel). 
For the European Community 
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... ANNEX: 
ISRAELI TEST FACILITIES 
CANDIDATES TO BE GLP RECOGNISED 
1. AGAN  CHEMICAL MANUFACTURERS LTD 
Address:  ASHOD 77102 
P.O.B. 262 
Tel.:  +972 8 515 211 
Fax:  +972 8 515 388 
2. AMINOLAB LTD Analytical Laboratory Services 
Address:  Weizmann Science Park 
P.O.B. 2407 
REHOVOT 76123 
Tel.:  +972 8 409 690 
Fax:  +972 8 408 474 
3. ANALYST  Research Laboratories 
Address:  Kiriat Weizmann 
P.O.B. 1176 
REHOVOT 76111 
Tel.:  +972 8 936 2034 
Fax:  +972 8 936 2039 
4. HARLAN  BIOTEC Israel Ltd. 
Address:  Weizmann Science Park, building 13B 
P.O.B. 12085 
REHOVOT 
Tel.:  +972 8 940 9451 
Fax:  +972 8 940 9452 
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DRAFT  I 
AGREEMENT 
on Mutual Recognition of  OECD principles 
of  Good Laboratory Practice (GLP) 
and (;ompliance Monitoring Programmes 
between the European Community and the State of  Israel 
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.d' The European Community (herinafter referred to as "the Community") 
on the one hand, 
and The State of Israel (herinafter referred to as "Israel") 
on the other hand, 
THE TWO PARTIES subsequently referred to as the Contracting Parties, 
HAVING regard to their obligations under the World Trade Organisation (WTO) and the 
WTO Agreement on Technical Barriers. to Trade, and especially to Annex I-C  thereof, 
concerning the protection of  intellectual property,  · 
HAVING regard to the OECD Council Decision of 12 May  1981  on mutual acceptance 
of  data for the evaluation of  chemicals, 
HAVING regard to the OECD Council Decision-Recommendation of  2 October 1989 on 
compliance with principles of  Good Laboratory Practice [C(89) 87(Final)] 
HAVING regard to the Agreement on the European Economic Area of 2 May 1992 that 
establishes a zone of free circulation of goods, services, people and capital between the 
European  Community  and  Iceland,  Liechtenstein  and  Norway  and  especially  to  its 
12th protocol,  · 
AFFIRMING the need to  ensure the  high quality, validity and reliability of health and 
environmental  data  generated  during  the  testing  of cosmetics,  industrial  chemicals, 
pharmaceuticals, food additives, animal feed additives, pesticides (hereinafter referred to 
as chemicals), 
NOTING that inthe absence of a national GLP monitoring authority in Israel, there is a 
need for transitional arrangements during an initial period during which Israel will set up 
this authority, 
HAVE AGREED AS FOLLOWS: 
ARTICLE 1 -Definitions 
1.  Unless  specific  definitions  are  given,  the  definition  of  terms  in  the 
"OECD Principles  of Good Laboratory  Practice"  [Annex  II  to  OECD  Council 
Decision C(81) 30 (Final)], the "Guides for Compliance Monitoring Procedures for 
Good  Laboratory  Practice"  [Annex  I  to  Council  Decision-Recommendation 
C(89)87(Final)],  the  "Application  of the  Good Laboratory  Practice principles  to 
field  studies"  (GLP  Consensus  document,  OECD  Series  on  Principles  of Good 
Laboratory Practice and Compliance Monitoring), and all amendments made thereto 
shall apply. 
14 2.  "Accept" means that the Receiving Authorities will be obliged to recognise studies 
and  data  generated  therefrom,  from  the  other  Party  on  products  subject  to  this 
Agreement  under  the  same  conditions  as  data  generated  on  their  own  territory, 
provided that: 
- the  study  was  conducted  by  a  test  facility  located  on  the  territory  of the 
Contracting Parties, 
the  study  is  performed  by  a  test  facility  that  has  been judged  to  operate  in 
compliance with the Good Laboratory Practice principles by the relevant national 
Good Laboratory Practice Monitoring Authorities. 
3.  "Monitoring Authority":  a management body with responsibility for monitoring 
Good  Laboratory  Practice  compliance  of test  facilities  within  the  territory  of 
administration and for discharging other such functions related to Good Laboratory 
Practice as may be nationally determined. 
ARTICLE 2 - ScoJ!.e 
1.  The Contracting Parties shall assure the high quality, validity and reliability of safety 
evaluation data obtained during non-clinical testing on all  chemicals as identified 
Annex 1 to this Agreement before they are placed on the market. 
2.  The Contracting Parties shall recognise the equivalence of each others' compliance 
:monitoring programmes on GLP that are in accordance with the principles referred to 
in Article 3, paragraph 1. 
3.  Each  Contracting Party shall  accept  studies  and  data generated  therefrom,  on the 
entirety of their territory  as  defined  in  Article  15,  produced by  the  test  facilities 
located on the territory of the other Contracting Party provided they participate in the 
GLP  compliance  monitoring  programme  of that  Party  in  accordance  with  the 
principles referred to in Article 3, paragraph 1. 
4.  Under the  tenns of this Agreement, the  studies and  the data generated therefrom, 
shall  be  used  by  the  Contracting  Parties  for  consideration  in  any  administrative 
action to  allow placing on the  market of all  chemicals as  defined  in Annex  1 to 
this Agreement. 
ARTICLE 3- Basis o(Reference 
1.  For the purpose of  this Agreement, the following conditions shall be fulfilled: 
the principles of Good Laboratory Practice  shall be  in conformity with those 
adopted by the OECD in its Decision of 12  May  1981  on mutual acceptance 
ofdata for  the evaluation of chemicals  [C(81)30(Final)]  and  all  amendments 
made thereto; 
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.. the  provisions  regarding  test  facility  inspection  and  study  audits  shall  be  in 
conformity \Vith those adopted by the Council of the OECD in the Annexes I-III 
to the 1989 Decision-Recommendation [C(89)87(Final)], that has been modified 
by hs Decision-Recommendation of 9 March  1995  [C(95)  8 (Final)],  and  all 
amendments made thereto; 
the test facilities shall be recognized to be in conformity with Good Laboratory 
Practice  in  accordance  with  the  principles  applicable  respectively  in the  EC 
..  and Israel. 
2.  The Contracting Parties shall inform each other in a timely manner of changes to 
their  legislation  that  may  affect  Good  Laboratory  Practice  compliance  standards 
or programmes. 
ARTICLE 4 - Field o(Application 
This Agreement applies to  studies  conducted by  test facilities  on all  chemicals either 
substances or preparations,  as  identified in Annex 1,  and to  data generated therefrom. 
Modifications to  this  Annex  shall  be  decided  by  the  Joint  Committee,  referred  to  in 
Article 10. 
ARTICLE 5-Monitoring Authorities 
1.  The authorities empowered or designated in their respective territories to verify the 
conformity of the test facilities with the principles of Good Laboratory Practice are 
listed in Annex 2 to this Agreement. 
2.  The  Contracting  Parties  shall  inform  and  consult  each  other  with  regard  to  any 
further authorities which they wish to be. included in this Agreement. Modifications 
to annex 2, by either adding or withdraWing authorities, shall be decided by the Joint 
Committee, referred to in Article 10. 
ARTICLE 6 -Information about GLP-recognized Test Facilities 
1.  The Contracting Parties shall provide each other at least annually with a list of the 
test facilities on their territory, which in the light of the results of  the inspections and 
study  audits  conform  to  Good  Laboratory  Practice,  as  well  as  of the  dates  of 
inspection or audit and their compliance status. 
2.  The Contracting Parties shall inform each other promptly when a test facility coming 
under the terms of paragraph  1 of this  Article,  which  states that  it  applies  Good 
Laboratory  Practice, fails  to  conform  to  such  practice  to  an  extent  which  may 
jeopardize the integrity or authenticity of  any studies it conducts. 
3.  The  Contracting  Parties  shall  provide  each  other  promptly  with  the  information 
referred to  in paragraph 1 about test facilities that in the light of the results of the 
inspections and study audits confonn to Good Laboratory Practice but have yet not 
been included in the list referred to in that paragraph. 
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1.  The  Contracting  Parties  shall  supply  each  other  with  any  necessary  additional 
information on a test facility inspection or study audit in response to  a reasonable 
request from the other Party. 
2.  Each Contracting Party may request further test facility inspection or study audits on 
. _the  other party's territory if there  is  a documented doubt as  to  whether a test was 
conducted in accordance with Good Laboratory Practice. 
3.  If in exceptional cases doubts persist and the Requesting Party can justify a special 
concern, and with the consent of  the test facility concerned, it may designate one or 
more experts of its Authorities to participate in a test facility inspection or the audit 
of  a study conducted by the authorities of  the other Party. 
ARTICLE 8 - Confidentiality 
1.  The Contracting Parties shall make provision for the maintenance of confidentiality, 
not only by Inspectors but also by any other persons who gain access to confidential 
information as a result of  GLP compliance monitoring activities; 
2.  The  Contracting  Parties  shall  ensure  that,  unless  all  commercially  sensitive  and 
confidential  information has  been  excised,  reports  of test  facility  inspections  and 
study  audits  are  made  available  only  to  Regulatory  Authorities  and,  where 
appropriate, to the test facilities inspected or concerned with study audits and/or to 
study  sponsors.  Test  facilities  can  freely  dispose  of the  reports  of test  facility 
inspection and study audits that concern them. 
ARTICLE 9 -Participation as Observer 
Each Contracting Party may, on request, participate as an observer in an inspection 
of a test facility conducted by the Authorities of the other Party with the consent of 
the test facility  concerned in order to maintain a continuing understanding of the 
other Party's inspection procedures. 
ARTICLE 10 -Joint Committee 
1.  A Joint Committee composed of  representatives of  both Parties shall be established. 
2.  The Joint Committee shall meet in order to resolve problems resulting from possible 
differences  of  view  and  practice  within  the  two  Parties,  to  ensure  proper 
implementation of  this agreement and to seek opportunities for further cooperation. 
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TRANSITIONAL PROVISIONS =:=J 
ARTICLE 11 
For an initial period -as a transitional arrangement- of a maximum of two years starting 
after the entry into force of  the Agreement, the following provisions shall apply: 
1.  Israel shall establish during this period a national GLP monitoring system 
2.  If  there is no agreement between the Parties that the above requirement has been met 
satisfactorily during the initial period, and if the two  Parties do  not decide after a 
joint review to prolong the initial period, the present Agreement ceases automatically 
to be valid. 
3.  The  initial  period  may  be  terminated  before  the  two  year  period,  provided  the 
Community has acknowledged that the Israeli  GLP monitoring system has entered 
into operation satisfactorily. 
ARTICLE 12' 
During  the  initial  period  referred  to  in  Articlell, the  empowered  authorities  in  the 
Community shall verify conformity of the test facilities with GLP in Israel, as de~cribed 
in the attached Agreed Minutes. The Community shall recognise any test facility found in 
conformity with GLP requirements.  · 
ARTICLE 13 
During the initial period referred to in Article 11, Israel shall accept the data coming from 
GLP recognised test facilities in the Community and the Community shall accept data 
coming from the Israeli test facilities GLP recognised by it according to Article 12. 
I 
FINAL PROVISIONS  I 
ARTICLE 14 
Either Party may terminate this Agreement by giving the other Party six months notice 
in writing. 
ARTICLE 15 
This  Agreement  shall  apply.  on  the  on.(:  hand,  to  the  territories  in  which the  Treaty 
establishing the European Community is  applied and under the conditions laid down in 
..._  that Treaty and, on the other hand, to the territory of  the State of  Israel. 
18 ARTICLE 16 
This Agreement shall be approved or ratified by the parties in acwrdanct~ with L~eir own 
procedures. It shaH  enter into force on the first day of the second month following the 
date  on  which  the  Parties  have  exchanged  notes  confim1ing  the  completion  of the 
respective procedures for the entry into force of  this Agreement. 
This  Agreement is drawn up in two originals  in the  Danish,  Dutch,  English,  Finnish, 
French, German, Greek,  Hebrew,  Italian,  Portuguese,  Spanish and Swedish languages, 
each of  these languages being equally authentic. 
IN WITNESS WHEREOF THE UNDERSIGNED, BEfNG DULY  AUTHORISED, HAVE 
SIGNED THIS AGREEMENT. 
For the Government of  the State of  Israel  For the European Community 
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• ANNEXl 
LIST 
of 
Chemicals Covered by the Agreement on Mutual Recogntion of 
the OECD Principles of Good Laboratory Practice 
and 
Compliance Monitoring Programmes 
between 
the European Community and the State Of  Israel 
Chemicals,  either  substance  or  preparations,  covered  in  the  Agreement  on  Mutual 
Recognition of  the OECD Principles of Good Laboratory Practice between the European 
Community and the State of  Israel are: 
cosmetics 
industrial chemicals 
pharmaceuticals I medicinal products 
food additives 
animal feed additives 
pesticides 
These  chemicals  are  defined  by  the  legal  instruments .  of the  country  of destination, 
which are: 
For the European Communitv: 
1.  Council Directive 92/32/EEC of  30.4.1992 
amending for the seventh time Directive 67 /548/EEC on the approximation of 
the laws, regulations and administrative provisions relating to the classification, 
packaging and labelling of  dangerous substances. 
OJ L 154, 5.6.1992, p.  1 
2.  Council Directive 83/228/EEC of 18.4.1983 
on the fixing of  guidelines for the assessment of  certain products used in animal 
nutrition. 
OJ L 126, 13.5.1983, p. 23 
3.  Council Directive 87118/EEC of 18.12.1986 
on the harmonisation of  laws, regulations and administrative provisions relating 
to the application of  the principles of  Good Laboratory Practice and the 
verification of their applications for tests on chemical substances. 
OJ L 15, 17.1.1987, p. 29 
20 4.  Council Directive 87/19/EEC of22.12.1986 
amending  Directhe  75/318/EEC  on  the  approximation  of fr.te  laws  of the 
Member States  relating  to  analytical,  phmmaco-toxicological  and  clinical 
standards and protocols in respect of  the testing of  proprietary medicinal products. 
OJ L 15, 17.1.1987, p. 31 
5.  Council Directive 87  /20/EEC of  22.1  ~.1986 
amending  Directive  81/852/EEC  on  the  approximation  of the  laws  of the 
Member States  relating  to  analytical,  pharmaco-toxicological  and  clinical 
standards and  protocols in respect ofthe testing of  veterinary medicinal products. 
OJ L 15, 17.1.1987, p. 34 
6.  Council Directive 87/21/EEC of22.12.1986 
amending Directive 65/65/EEC on the approximation of previsions laid down by 
law, regulation or admmistrative action relating to proprietary medicinal products. 
OJ L 15, 17.1.1987, p. 36 
7.  Council Directive 87/153/EEC of  16.2.1987 
fixing guidelines for the assessment of  additives in animal nutrition. 
OJ 64, 7.3.1987, p. 19 
8.  Council Directive 88/320/EEC of  9  .. 6.1988 
on the inspection and verification of  Good Laboratory Practice (GLP). 
OJ L 145, 11.6.1988, p. 35 
9.  Council Directive 88/379/EEC of7.6.1988 
on the approximation of  the laws, regulations and administrative provisions of  the 
Member States relating to the classification, packaging and labelling of  dangerous 
preparations. 
OJ L 187, 16.7.1988, p. 14 
10.  Council Decision 89/569/EEC of28.7.1989 
on  the  acceptance  by  the  European  Economic  Community  of  an  OECD 
decision/recommendation  on  compliance  with  principles  of  Good 
Laboratory Practice. 
OJ L 315,28.10.1989, p. 1 
11.  Commission Directive 90/18/EEC of  18.12.1989 
adapting to technical progress the Annex of  Council Directive 88/320/EEC on the 
inspection and verification of  Good Laboratory Practice (GLP). 
OJ L 11, 13.1.1990, p. 37 
12.  Council Directive 91/414/EEC of 15.7.1991 
concerning the placing of  plant protection products on the market. 
OJ L 230, 19.8.1991, p. 1 
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' 13.  Commission Directive 911507/EEC of 19.7.1991 
14. 
15. 
modifying the Annex to Council Directive 75/318/EEC on the approximation of 
the  laws  of Member  States  relating  to  analytical,  pharmacotoxicological  and 
clinical standards and protocols in respect of the testing of medicinal products. 
OJ  L 270, 26.9.1991, p. 32 
(the  Standing Committee for  Propriety Medicinal  Products adopted a list of 10 
tests that must be considered as safety tests under GLP testing requirements, that 
is  included  in part II b of the  Notice  to  the  Applicant for  Authorisation  of a 
Medicinal  Product  for  Human  Use  in  the  Community,  document  III/3024/92 
Rev. 1). 
Council Regulation (EEC) No 793/93 of23.3.1993 
on the evaluation and control of  the risks of  existing substances  . 
. OJ L 84, 5.4.1993, p.  1 
Council Directive 93/35/EEC of 14.6.1993 
amending for the sixth time Directive 761768/EEC on the approximation of  the 
laws of  the Member States relating to cosmetic products. 
OJ 151, 23.6.1993, p. 32 
16.  Commission Directive 93171/EEC of27.7.1993 
amending Council Directive 911414 concerning the placing of  plant protection 
products on the market. 
OJ L 221, 31.8.1993, p. 27 
17.  Commission Directive 95/35/EC of 14.7.1995 
ame~ding Council Directive 911414/EEC concerning the placing on the market of 
plant protection products on the market (text with EEA relevance). 
OJ L 172, 22.7.1995, p. 6 
For Israel: See next page 
22 Pllarmacists Ordinanee: (New Versioo)- 1981 
~acist  Regulatiofts (Medical Prepamrions)- l936,  · 
Food Additives 
Puhlic Health Ordinance (Food) (New Version) - 1983 
Public Health Regulations (Food) (Bases of  Emulsifier and Stabilizers in Food Products)- 1966 
Public Health Regulations (Food) (Dietetic Food and Sweeteners)- 1987 
Public Health Regulations (Food) (Vitamin and Mineral Additives in Food)- 1983 
Public Health Regulations (Food) (Food Coloring) - 1984 
Public Health Regulations (Food) (Sealing of  Food Packaging)- 1993 
Public Health Regulations (Food) (Pesticide Traces) - 1991 
Public Health Regulations (Food) (Aflatoxins in Food)- 1989 
Public Health Regulations (Food) (Provisions of  Findings)- 1980 
Public Health Regulations (Food) (Labeling)- 1935 
Public Health Regulations (Food) (Nutritional Labeling) - 1993 
Public Health Regulations (Food) (Food Product Preservation through Radiation)- 1988 
Common Health Ordinance - 1942 
Common Health Regulations (Sanitary Quality of  Drinking Water)- 1977 
Common Health Regulations (Mineral and Spring Water)- 1987 
Common Health Regulations (Method of  Taking Samples and their Transfer for Testing)- 1957 
Common Health Regulations (Preservative Bases in Food Goods)- 1965 
Commodities and Services Control Law- 1957 
Commodities and Services Control Order (Quality of  Food)- 1958 
Commodities and Services Control Order (Production of  Food Products) - 1976 
Commodities and Services Control Order (Labeling ofFood Additives)- 1968 
Animal Feed Additives 
Commodities and Services Control Order (Production and Sale of  Fodder)- 1971 
Animal Disease Ordinance (New Version)- 1985 
Animal Disease Regulations (Chemical Preparations) - 1982 
Pesticides 
Commodities and Services Control Order (Pesticide Preparations Against Hazards to humans)-
1962 
Hazardous Substances Regulations (Registration of Pesticide Preparations Against Hazards to 
Humans)- 1994 
; Plant Protection Law - 1956 
Plant Protection Regulations (Regulation oflmport and Sale of  Chemical Preparations)- 1994 
Agricultural Fertilizers Ordinance - 1938 
Agricultural Fertilizers Regulations- 1938 
23 
., Cosmetics 
Commodities and Services Control Order (Cosmetics)- 1973 
Industrial Chemicals 
Hazardous Substances Law - 1993 
Hazardous Substances Regulations - 1994 
Hazardous Substances Regulations (Import and Export of  Hazardous Substances Waste) - 1994 
Hazardous Substances Regulations (Classification and Exemption)- 1996 
Note: the translation of  this legislation list into English is unofficial. 
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ISRAEL  fur ali 
AUSTRIA  for ali 
BELGIUM  for all: 
ANNEX2 
LIST 
of 
MDdoring  Authorities  I 
ISitA.EL: 
Israel Laboratory 
Accreditation Authority 
Haboaim Street, 2 
Ramat Gan 52522 (Israel) 
EUROPEAN COMMUNITY: 
Fe<lerai  Minisny  of the  Environment, 
Youth and the Family 
Department II/2° 
Stubenbastei s 
A-1010Wten 
Institut d'Hygiene et d'Epidemiologie 
Rue Juliette Wytsmanstraat 14 
B-1  050 Bruxelles/Brussel 
DENMARK  for industrial  ~hemicals 
and pesticides: 
National Agency of  Industry and Trade 
Tagensvej 137 
for medicinal products: 
FINLAND  for all 
DK-220 Copenhagen N 
National  Board  of Health,  Medicines 
Division 
378, Frederikssundsvej 
DK  ~2700  Bronshoj 
The National Product Control Agency 
for Welfare and Health 
P.O.Box210 
SF-00531 Helsinki 
Finland 
25 ... 
,. 
FRANCE  for industrial chemicals, 
pesticides and others 
than pharmaceuticals: 
for pharmaceuticals other : 
than veterinary products 
for cosmetics 
for veterinary products 
GERMANY  for all: 
GREECE  for all: 
IRELAND:  for all: 
ITALY  for all: 
Groupe Interministeriel des 
Produits Chimiques (GIPC) 
3/5 Rue Barbet de Jouy 
F-75353 Paris 07 SP 
Agence du Medicament 
143/147 Boulevard Anatole France 
F-93200 Saint Denis 
Ministere  de  la  Sante,  Direction 
Generale  de  la  Sante,  Sous-direction 
pharmacie 
1, place de Fontenoy 
F-75350 Paris 07 SP 
CNEV  A,  Agence 
veterinaire,  service 
controles 
BP203 
du  medicament 
inspections  et 
F-35302 Fougeres Cedex 
Federal  Ministry  for  the  Environment, 
Nature Conservation and Nuclear Safety 
Div. IG II 3 
D-53048 Bonn 
General Chemical State Laboratory 
An Tsoha street, 16 
GR-11521 Athens 
Irish National Accreditation Board 
Wilton Park House, 
Wilton Place 
IRL-Dublin 2 
Ministero della Sanita, 
Dipartimente Prevenzione 
GLP Compliance Monitoring Unit 
Via della Sierra Nevada, 60 
1-00144 Roma 
26 NETHERLANDS for all: 
PORTUGAL  for industrial chemicals 
and pesticides: 
SPAIN 
SWEDEN 
for pharmaceuticals 
and veterinary drugs: 
for pharmaceuticals 
for pharmaceuticals, 
hygiene and comestic products 
for all other products 
UNITED KINGDOM  for all: 
Inspectorate  for  Health  Protection, 
Commodities and Veterinary Public Health 
GLP Department 
Ministry of  Health, Welfare and Sports 
P.O. Box 16.108 
NL- 2500 BC 's-Gravenhage 
Instituto Portugues da 
Qualidade 
Rua Jose Estevao, 83-A 
P-1199 Lisboa Codex Portugal 
Direc~ao Gearl dos Assuntos 
Farmaceuticos 
Av. Estados Unidos da America, 37, 10° 
P-1700 Lisboa Portugal 
Direci6n General de Farmacia y 
Productos Sanitarios 
Passeo del Prado, 18-20 
E-28014 Madrid 
Uikemedelsverket 
(Medical Products Agency) 
Box26 
S-751  03 Uppsala 
Styrelsen fOr zck"edi;crlng och teknisk 
kontroll 
(Swedish Board for Accreditation 
and conformity Assessment). 
Box 2231 
S-1 0315 Stockholm 
GLP  Monitoring  Unit,  Division  of 
Medical  Toxicology  and  Environment 
Health, Department of  Health 
Hannibal House 
Elephant and Castle 
UK-London SEl 6TE 
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Financial Statement 1998-2002 
External trade relations - Mutual Recognition Agreement 
1.  TITLE 
External Trade Relations.: 
Mutual Recognition Agreements with United  States,  Canada,  Australia,  New  Zealand· 
and Israel. 
2.  BUDGETARY HEADINGS:  B7-8SOO 
A-7010 
3.  LEGAL BASIS 
•  Article 113 of  the Treaty of  Rome 
•  Proposal  for  Council  Decisions  No  ....  on  the  implementation  by  the 
European Commission  of mutual  recognition  agreements  with  United  States, 
Canada, Australia, New Zealand and Israel. 
4.  DESCRIPTION OF OPERATION: 
4.1  General objective: 
The purpose of  these agreements is to establish mutual recognition of  certification of 
conformity  of products  with  technical  regulations  or  standards  of partners  to 
the agreement. 
The major actions which will be pursued by the Commission under this budget line 
will be the following: 
•  Confidence-building  activities  to  facilitate  the  proper  implementation  of the 
Agreement. 
•  Management  of the  Agreements  and  maintenance  of the  necessary  degree 
of  confidence. 
The  Commission  will  be  assisted  by  experts,  particularly  in  regard  to 
sectoral activities.  It will however remain the  final  arbiter  in the  management of 
these agreements. 
4.2 Duration of  the action; means foreseen for its renewal: 
The general action undertaken will be of an indefinite duration. The initial period of 
confidence-building required by the Agreements will require a more intensive effort 
and expenditure, but this should be substantially less after 2 years. However, during 
the life of the Agreements a continued effort will be needed to ensure management 
and maintenance of  confidence. 
28 5.  CLASSIFICATION OF EXPENDITURE/REVENUE 
5.1 Non-compulsory expenditure ("DNO'~ 
5.2 Differentiated appropriation ("CD'~ 
5.3 Type ofrevenueinvolved: 
None 
6.  TYPE OF EXPENDITURE/REVENUE 
I 00% subsidy: No 
subsidy for co-financing with other sources in the public or private sector? 
Yes,  this  may  be  envisaged  as  a  method  of funding.  Subsidies  not  normally 
exceeding 50% will be provided to professional associations and other responsible 
organisations for activities related to the implementation of  the Agreement. 
Interest subsidy: No 
Others 
Financing of  events, acquisition of  studies, publications and conferences. 
Should the action prove an economic success,  is there provision for all,  or part 
of, the Community contribution. to be reimbursed? 
Not relevant 
Wil' the proposed operation cause any changes in the level of  revenue? 
No 
7.  FINANCIAL IMPACT ON APPROPRIATIONS FOR OPERATIONS 
7.1  Method of  calculating the total cost of  the operation: 
The estimation of  costs is based on the anticipated requirements in terms of expenses 
related to training, seminars, workshops, travel of experts, verification of conformity 
assessment bodies, information and studies. The total estimated cost is based on the 
sum of  the individual actions. 
A range of  different actions are foreseen to meet the objectives of  the budget-line and 
costs will vary depending on the nature of  action undertaken.  Even for similar types 
of  action (e.g. seminars) costs will vary depending on the scope of  the action and the 
degree of  specialisation needed. 
29 
,'  -··  '•  ~ •· 
The costs of  specific actions will be determined either: 
•  by the Commission when it organises activities itself, e.g. seminars 
•  following invitations to tender issued by the Commission 
•  following requests for subsidies.  In such cases, projects are selected according 
to  how well they meet the criteria which have been established for  selection. 
Subsidies are based on a percentage of total costs and usually the Community 
funding is limited to a maximum of  50%. 
A.  Attendance at Joint Committee 
These will be attended by  Commission officials and some national experts. Travel 
and per diem expenses should be foreseen within the normal range of  such expenses. 
B.  Attendanc~ at Joint Sectoral Groups 
These will also be attended by Commission officials and given the nature of these 
meetings  a  larger  contingent  of national  experts.  Travel  and  per  diem  expenses 
should be foreseen within the normal range of  such expenses. 
C.  Workshops and Seminars 
These will be held to familiarise economic and other operators with the requirements 
of the  Agreement.  The cost of these  seminars will  vary according  to  the  subject 
matter  and  location,  and  will  include  organisational  costs  (when  in  Europe)  and 
substantial travel costs when in the territory of the partner country.  Organisational 
costs  in  Europe  will  cost  EUR 3 000  each.  The  number  of seminars  will  vary 
depending on the individual industrial sectors covered by the Agreement. 
D.  Verification actions 
The competence of the conformity assessment bodies (CABs) will  in many cases 
have to be checked, more so in the initial period of  the Agreement, but as a matter of 
course throughout the life of  the Agreement to maintain confidence in the system. 
This will involve on-site assessment by teams of experts of conformity assessment 
bodies  in the  partner country in the  initial  stages,  and subsequently investigation 
of  complaints..  This  expenditure  will  be  essential  in all  sectors of the  Agreement 
(  ... in  number)  and  may  involve  numerous  CABs  in  each  sector  including  at 
subfederal or local level in certain cases. 
E.  Production and dissemination of  information 
Certain  costs  may  need  to  be  incurred  for  the  dissemination  of information. 
Guides to regulations and assessment procedures may be needed typically at a cost of 
EUR 10000. 
30 7.2  Breakdown by elements of  the operation 
"Trade Agreements with important Trading Partners" 
For 1998, this involves the following calculation: 
Budget Heading  Amounts  Method of  calculation 
(EUR) 
No. of missions  Standard Unit cost 
Joint Committee  12 940  Bxl  2  US: Travel: EUR 2 000; 
Bxl  2  per diem: EUR 185 
B7-8500  Aus/NZ  2 
Israel  1 
Sectoral Groups  57 680  Bxl  16  CAN: Travel: 
B7-8500  us  8  EUR 1 750; per diem: 
CAN  8  EUR 170 
Seminars  103 540  us  10  Aus I NZ: Travel: 
CAN  10  EUR 3 200; per diem: 
B7-8500  Aus/NZ  14  EUR 190  -
Bxl  28 
Verifications  142 150  us  18  Brussels: Travel: 
CAN  18  EUR 800; perdiem: 
B7-8500  Aus/NZ  12  EUR 110 
Israel  1 
Information  10 000 
B7-8500 
B7-8500  Total  326 310  150 
31 InEUR 
(current prices). 
Breakdown  Year  Year 
1998  1999  2000  2001  2002  Total 
1998-2002 
A. Joint Committee  12.940  13 760  12 940  13 760  12 940  66 340 
B7-8500 
B. Joint Sectoral Groups  57 680  57 680  57 680  57 680  57 680  288 400 
B7-8500 
C. Seminars  103 540  96 310  199 850 
B7-8500 
D. Verifications  142 150  142 150  48 430  48430  48430  429 590 
B7-8500 
E. Information  10000  10 000  10000  30 000 
B7-8500 
B7-8500  Total  326 310  319 900  129 050  119 870  119 050  I 014 180 
Indicative financial programming subject to the annual budget procedure. 
7.3  Indication of  the timetable for commitment and payment appropriations 
1000 EUR 
Year  2003 
1998  1999  2000  2001  2002  and  Total 
fo11owing 
years 
Schedule  of  326  319  129  119  119  119'  1 131 
Commitment 
Payment 
appropriations 
1998  326  326 
1999  319  319 
2000  129  129 
2001  119  119 
2002  119  119 
2003  119  119 
Total  326  319  129  119  119  119  1 131 
32 8.  WHAT  ANTI-FRAUD  MEASURES  ARE  PLANNED  IN  THE  PROPOSAL 
FOR THE OPERATION? 
Methods of control (submission of reports,  etc.)  will  be  included  in  all  contracts 
between the Commission and beneficiaries. 
A close cooperation with the delegations of the Commission and the participation of 
a representative of  the Commission at events in third countries will check on the spot 
the  work  to .  ensure  that  it  corresponds  with  the  terms  of reference,  contract 
provisions and required professionalism. 
The  checks  take  place  before  the  fmal  payment.  The  same  rule  applies  to  the 
financial incentives paid to participating companies. Where appropriate, agreements 
also require organisations to submit financial accounts certified by their auditors. 
In those cases involving cooperation with EU industrial federations the accounts are 
further checked at the Annual General Meeting of  the federations concerned. 
9.  ELEMENTS OF COST-EFFECTIVENESS ANALYSIS 
9.1.  Specific objectives ofthe proposed operation, population targeted 
- The specific objectives of  mutual recognition agreements are: 
•  to avoid duplication of  certification by economic operators. 
•  to promote exports, employment, competitivity and investment. 
•  to  reduce  costs,  in  particular  for  small  and  medium-sized  enterprises  and 
ultimately for the consumer. 
- Target population 
The target population are the exporting companies, business associations, chambers 
of commerce  and  public  institutions  of the  European  Union  and  the  general 
consumer  which  will  benefit,  or  have  an  interest  in,  the  mutual  recognition 
of  certification. 
33 9.2.  Reasons for the operation 
- Need  for intervention from the Community budget 
Under Article 113 of  the Treaty of Rome the Community has exclusive competence 
for commercial policy and these agreements have been negotiated in accordance with 
a mandate of the Council of Ministers and in consultation with the  113  Committee. 
The  Commission  will  be  responsible  for  implementation  and  management  of 
the agreements. 
- Choice of  methods of  intervention 
*  advantages over alternative measures (comparative advantages) 
*  analysis of  similar operations at Community or national/eve/ 
*  results and expected multipliers 
The choice of management method  (Joint Committee  and  Joint Sectoral  Groups) 
have been set out in the  Agreements and constitute a minimum necessary for  the 
proper functioning of  the Agreement. The Agreements also contain provisions for the 
use of  seminars in the initial phases to ensure familiarity with other systems. 
These  seminars  and  verifications  are  also  designed  to  build  mutual  confidence; 
verifications will also be required to ensure this confidence is maintained throughout 
the life of  the agreements. Confidence and its maintenance are keys to the successful 
operation of  the agreements. 
The importance of this budget is justified when put in perspective with the  trade 
involved  in  these  agreements  and  the  yearly  savings  for  EU  exporters  which  are 
expected (estimated on a yearly basis at EUR  190 million for  EU exporters to the 
US,  EUR 20 million in the  case  of exports to  Canada and 40  mio ·  in the  case  of 
exports to Australia and New Zealand). 
- Main factors  of uncertainty  which  could affect  the  specific  results  of 
the operation. 
*None 
34 9.3  Monitoring and evaluation of  the operation 
- Performance indicators selected 
* Output indicators 
*  indicators of  impact, following the objectives chosen 
In  the  case  of these  Agreements,  success  can  be  quantified  by  trade  facilitation 
through  avoidance  of duplication  of testing  and  certification  and  costs.  Yearly 
estimated savings for the European Community are indicated above (9.2). 
Success can also be measured by increased EU exports and this factor will be taken 
into consideration although export performance is subject to  such a wide range of 
variables  (e.g.  changes  in  exchange ,rates)  that this  can  never  be  the  sole  factor 
for evaluation. 
- Evaluation of  results 
Progress  in  the  attainment  of the  Agreements  objectives  will  be  monitored  by 
Commission  officials,  Committees  established  under  the  Agreements  and  by  the 
economic operators concerned. 
Details and  frequency of  the planned evaluation 
The  evaluation of the effectiveness and  usefulness  of the agreements wil  be  regularly 
monitored by the Commission and by the Committees established under the agreements 
at their annual meetings. The first major evaluation will be at the end of the confidence-
building period. 
10.  ADMINISTRATIVE EXPENSES 
Actual  mobilisation  of the  necessary  administrative  resources  will  depend  on  the 
Commission's annual  decision on the allocation of resources,  taking  into  account  the 
number of  staff and additional amounts authorised by the budgetary authority. There is no 
request for additional staff. 
35 
i ·1 0.1  Effect on the number of  posts 
Type of  post  Staff  to be assigned to  Source  Duration 
managing the operation 
Permanent  Temoorarv  Existing  Additional 
posts  ~  esources in  esources 
he DGs or 
DGI  ~epartments 
+  poncerned 
sectoral DGs 
Officials  A  3.5  None  3.5  None  Permanent 
B 
c  1  1 
Other resources  None 
Total  4.5  4.5 
10.2  Overall financial impact ofhuman resources: 4.5 staff(EUR 107 500 per staff 
member per year= EUR 483 750). 
10.3  Increase in other administrative expenditure as a result of  the operation 
(A-7010: travel expenses) 
The expenses set out below relate to  travel  expenses for  officials of the Commission 
attending  meetings  of  the  Joint  Committee,  joint  sectoral  groups,  seminars  and 
verifications, when these are outside Brussels. These will be taken care of  by the relevant 
budget allocations of  various Directorates Generals involved. 
36 For 1998 this involves the following calculation: 
Budget heading  Amounts (EUR)  Method of  calculation 
No. of  missions  Standard Unit cost 
Joint Committee  Aus/NZ  4  US: Travel: EUR 2 000; 
Israel  4  per diem: EUR 185 
A-7010  22 120 
Sectoral Groups  us  4  CAN: Travel: 
CAN  4  EUR 1 750; per diem: 
A-7010  20 680  EUR 170 
Seminars  us  4  Aus I NZ: Travel: 
CAN  4  EUR 3 200; per diem: 
A-7010  20680  Aus/NZ  EUR 190 
Verifications  us  18 
CAN  18 
A-7010  142 150  Aus/NZ  12 
Israel  1 
A-7010  Total  205 630  73 
InEUR 
Year  Year  Total 
1998  1999  2000  2001  2002  1998-2002 
A. Joint Committee 
22 120  20 680  22120  20680  22 120  107 720 
A-7010 
B  Joint  Sectoral 
Groups  20680  20 680  20680  20 680  20680  103 400 
A-7010 
C. Seminars 
20680  18 260  38 940 
A-7010 
D. Verifications 
142  142  48430  48 430  48430  429 590 
A-7010  150  150 
I 
A-70iO  205  201  91230  89790  91230  679 650 
TOTAL  630  770 
I 
37 IMPACT ASSESSMENT FORM 
THE IMPACT OF THE PROPOSAL ON BUSINESS 
with special reference to small and medium-sized enterprises 
Title of  proposal 
Proposal  for  a  Council  Decision  on  the  conclusion  of an  agreement  between  the 
European Community  and  Israel  on  mutual  recognition  of OECD  principles  of good 
laboratory practice and compliance monitoring programmes.  · 
Reference number 
The proposal 
A  Council  Decision  is  needed  to  conclude  an  agreement  between  the 
European Community  and  Israel  on mutual  recognition  of OECD principles  of good 
laboratory  practice  and  compliance  monitoring  programmes.  The  agreement  was 
negotiated  and  initialled  by  the  Commission  in  accordance  with  the  mandate  and 
negotiating directives provided by the Council. 
The impact on business 
The  products  involved  are  chemicals  used  in  cosmetics,  industrial  chemicals, 
pharmaceuticals, food additives, animal feed additives and pesticides. 
Studies and data from the laboratories of the two parties to the agreement can be used, so 
that no further studies are needed before marketing. 
The  agreement  therefore  has  important  advantages  from  the  point  of  view  of 
transparency, market access, and ease of  trade and in particular makes it possible to avoid 
duplicating  costs.  All  this  is  of particular  importance  for  small  and  medium-sized 
enterprises. 
The agreement covers a wide range of  products manufactured throughout the Community 
and a large number of firms, both big and small, in these sectors. The advantages are not 
limited to specific geographical areas in the Community. 
The  agreement  will  substantially  reduce  marketing  costs  and  will  improve  European 
firms' prospects for exports, employment, investment and competitiveness. 
The  agreement does not contain measures to  take account of the  specific  situation of 
small and medium-sized firms, but by its nature and by reducing costs that are the same 
for  all  firms,  the agreement  will,  proportionately,  be  of greater  benefit  to  small  and 
medium-sized enterprises than to large companies. 
38 Consultation 
The  main  trade  organisations  in  the  industrial  sectors  concerned  have  been 
consulted (CEFIC, COLIPA,  EFPIA,  AESGP) and  have  declared their full  support for 
the Agreement. 
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